Medical Indemnity Legislation Amendment (Competitive Neutrality) Act 2005

Administered by Department of Health, Disability and Ageing

Legislation au C2005A00126 In force Act

Legislation content

 

 

 

 

 

 

Medical Indemnity Legislation Amendment (Competitive Neutrality) Act 2005

 

No. 126, 2005

 

 

 

 

 

An Act to amend the Medical Indemnity Act 2002 and the Medical Indemnity (UMP Support Payment) Act 2002, and for related purposes

 

 

Contents

1 Short title

2 Commencement

3 Schedule(s)

Schedule 1—Competitive advantage payment

Health Insurance Act 1973

Health Insurance Commission Act 1973

Medical Indemnity Act 2002

National Health Act 1953

Schedule 2—UMP support payment

Medical Indemnity Act 2002

Medical Indemnity (UMP Support Payment) Act 2002

Schedule 3—Technical correction

Medical Indemnity Act 2002

 

 

 

Medical Indemnity Legislation Amendment (Competitive Neutrality) Act 2005

No. 126, 2005

 

 

 

An Act to amend the Medical Indemnity Act 2002 and the Medical Indemnity (UMP Support Payment) Act 2002, and for related purposes

[Assented to 19 October 2005]

The Parliament of Australia enacts:

1  Short title

  This Act may be cited as the Medical Indemnity Legislation Amendment (Competitive Neutrality) Act 2005.

2  Commencement

 (1) Each provision of this Act specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provision(s)

Commencement

Date/Details

1.  Sections 1 to 3 and anything in this Act not elsewhere covered by this table

The day on which this Act receives the Royal Assent.

19 October 2005

2.  Schedules 1 and 2

1 July 2005.

1 July 2005

3.  Schedule 3

Immediately after the commencement of Schedule 2 to the Medical Indemnity Legislation Amendment (Runoff Cover Indemnity and Other Measures) Act 2004.

1 July 2004

Note: This table relates only to the provisions of this Act as originally passed by the Parliament and assented to. It will not be expanded to deal with provisions inserted in this Act after assent.

 (2) Column 3 of the table contains additional information that is not part of this Act. Information in this column may be added to or edited in any published version of this Act.

3  Schedule(s)

  Each Act that is specified in a Schedule to this Act is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this Act has effect according to its terms.


Schedule 1—Competitive advantage payment

 

Health Insurance Act 1973

1  Subsection 130(25) (after paragraph (a) of the definition of medical indemnity legislation)

Insert:

 (aa) the Medical Indemnity (Competitive Advantage Payment) Act 2005; and

Health Insurance Commission Act 1973

2  After paragraph 42(2)(a)

Insert:

 (aa) the Medical Indemnity (Competitive Advantage Payment) Act 2005;

Medical Indemnity Act 2002

3  At the end of subsection 3(4)

Add:

 ; and (c) to require a payment from medical indemnity insurers to ensure that the assistance referred to in paragraph (2)(c) does not give a competitive advantage to the organisations that receive that assistance.

4  Subsection 4(1) (at the end of the definition of contribution year)

Add:

 ; and (c) for a competitive advantage payment—has the same meaning as in the Medical Indemnity (Competitive Advantage Payment) Act 2005.

5  Subsection 4(1) (at the end of the definition of medical indemnity payment)

Add:

 ; or (c) a competitive advantage payment payable under Division 2A of Part 3.

6  Subsection 4(1) (at the end of the definition of medical indemnity payment legislation)

Add:

 ; or (c) the Medical Indemnity (Competitive Advantage Payment) Act 2005.

7  Subsection 4(1)

Insert:

net IBNR exposure has the meaning given by section 8A.

8  After section 8

Insert:

8A  Net IBNR exposure of an MDO

  An MDO’s net IBNR exposure at a particular time is the MDO’s IBNR exposure at that time, reduced by any amounts of high cost claim indemnities and runoff cover indemnities that are likely to be payable in respect of the incidents that satisfy subsection 8(2) and that relate to the MDO’s IBNR exposure at that time.

9  Paragraph 40(1)(d)

After “IBNR exposure”, insert “, or its net IBNR exposure,”.

10  After Division 2 of Part 3

Insert:

Division 2A—Competitive advantage payment

Subdivision A—Introduction

59A  Guide to the competitive advantage payment provisions

 (1) The Medical Indemnity (Competitive Advantage Payment) Act 2005 (the Payment Act):

 (a) imposes payments on medical indemnity insurers for contribution years; and

 (b) specifies the amount of those payments (by reference to the net IBNR exposure of the insurer’s participating MDO for the contribution year).

This Division contains further provisions relating to the payment.

 (2) The following table tells you where to find the provisions dealing with various issues:

 

Where to find the provisions on various issues

Item

Issue

Provisions

1

which years are contribution years?

section 5 of the Payment Act

2

who must pay the competitive advantage payment?

section 59B of this Act

3

who is exempt from the competitive advantage payment?

section 59C of this Act

4

what is the amount of the competitive advantage payment?

section 6 of the Payment Act

5

what is the time for paying the competitive advantage payment?

section 61 of this Act

6

when is late payment penalty payable?

section 65 of this Act

7

what method should be used to pay the competitive advantage payment?

section 66 of this Act

8

what happens if an amount of competitive advantage payment is overpaid?

section 67 of this Act

9

how are competitive advantage payments and late payment penalties recovered?

sections 68 to 70 of this Act

10

what information has to be provided to the HIC about competitive advantage payment matters?

sections 71 and 72 of this Act

Subdivision B—Who pays competitive advantage payment

59B  Who is liable to pay the competitive advantage payment

  A person is liable to pay a competitive advantage payment for a financial year if:

 (a) the person is a medical indemnity insurer; and

 (b) the financial year is a contribution year; and

 (c) the person is not exempt from the payment under section 59C.

59C  Exemptions

 (1) The regulations may provide that a person is exempt from competitive advantage payment in the circumstances specified in the regulations.

 (2) Regulations made for the purposes of subsection (1) may provide that a person is exempt from competitive advantage payment either generally or for a particular contribution year.

Subdivision C—Annual reassessment of participating MDO’s net IBNR exposure

59D  Object of this Subdivision

  The object of this Subdivision is to allow annual reassessment and publication of a participating MDO’s net IBNR exposure so that the competitive advantage payment reflects the competitive advantage that the participating MDO and any associated insurer enjoy.

59E  Process for annually reassessing net IBNR exposure

Report by the Actuary

 (1) For each contribution year for a participating MDO, the Actuary must give the Minister a written report that:

 (a) states the Actuary’s assessment of the MDO’s net IBNR exposure as at the end of the financial year that ends immediately before the start of that contribution year; and

 (b) sets out the reasons for the assessment.

 (2) In preparing the report, the Actuary must take into account any information that the HIC gives the Actuary in relation to the MDO under subsection (6).

HIC’s information gathering powers

 (3) If the HIC believes on reasonable grounds that a participating MDO is capable of giving information that is relevant to assessing the MDO’s net IBNR exposure as at the end of a financial year that ends immediately before the start of a contribution year for the MDO, the HIC may request the MDO to give the HIC the information.

Note: Failure to comply with the request is an offence (see section 73).

 (4) Without limiting subsection (3), the kind of information that may be requested includes information in the form of:

 (a) financial statements; and

 (b) a report prepared by a suitably qualified actuary assessing the MDO’s net IBNR exposure as at the end of a financial year that ends immediately before the start of a contribution year for the MDO.

 (5) The request:

 (a) must be made in writing; and

 (b) must state what information the MDO is to give to the HIC; and

 (c) may require the information to be verified by statutory declaration; and

 (d) must specify the day on or before which the information must be given; and

 (e) must contain a statement to the effect that a failure to comply with the request is an offence.

The day specified under paragraph (d) must be at least 28 days after the day on which the request is made.

 (6) The HIC must give any information that the MDO gives the HIC to the Actuary for the purposes of preparing the report for the Minister under subsection (1).

Publishing net IBNR exposure

 (7) The Minister must cause to be published in the Gazette a notice of the amount of any net IBNR exposure of an MDO stated in a report to the Minister under subsection (1).

 (8) A notice made under subsection (7) is not a legislative instrument.

11  Subsection 60(1)

Omit “and runoff cover support payments”, substitute “, runoff cover support payments and competitive advantage payments”.

12  Section 61 (at the end of the table)

Add:

3

competitive advantage payment

(a) 30 April in the contribution year; or

(b) such other day as is specified in the regulations as the payment day for the contribution year either generally for all people, for the class of people that includes the person or for the person, as the case may be.

13  After paragraph 73(1)(a)

Insert:

 (aa) subsection 59E(3); or

National Health Act 1953

14  Subsection 135A(24) (after paragraph (a) of the definition of medical indemnity legislation)

Insert:

 (aa) the Medical Indemnity (Competitive Advantage Payment) Act 2005; and


Schedule 2—UMP support payment

 

Medical Indemnity Act 2002

1  Paragraph 52(2)(ca)

Omit “income period was less than $5,000; or”, substitute:

  income period was:

 (i) if the contribution year started on 1 July 2003 or 1 July 2004—less than $5,000; or

 (ii) otherwise—less than or equal to $50,000; or

2  Paragraph 52(2)(cb)

Omit “income period was less than $5,000; or”, substitute:

  income period was:

 (i) if the contribution year started on 1 July 2003 or 1 July 2004—less than $5,000; or

 (ii) otherwise—less than or equal to $50,000; or

3  After paragraph 52(2)(cb)

Insert:

 (cc) the contribution year started on or after 1 July 2005 and the applicable percentage of the annual subscription for the base year of a participating member of a participating MDO is less than or equal to $1,000; or

4  Paragraph 52(2)(db)

Omit “6”, substitute “4”.

5  After subsection 52(3A)

Insert:

 (3AA) For the purposes of paragraph (2)(cc):

 (a) annual subscription and base year have the same meanings as in section 54 of this Act; and

 (b) applicable percentage has the same meaning as in section 6 of the Medical Indemnity (UMP Support Payment) Act 2002.

Medical Indemnity (UMP Support Payment) Act 2002

6  Paragraph 6(1)(a)

Omit “$5,000”, substitute “$4,000”.

7  Paragraph 6(1)(b)

Repeal the paragraph, substitute:

 (b) the amount by which the applicable percentage of the member’s annual subscription for the base year exceeds $1,000; and

8  Paragraph 6(1)(c)

Omit “the member’s gross Medicare billable income for the income period for that contribution year”, substitute “the amount by which the member’s gross Medicare billable income for the income period for that contribution year exceeds $50,000”.

9  Paragraph 6(1)(d)

Omit “the member’s gross medical income for the income period for that contribution year”, substitute “the amount by which the member’s gross medical income for the income period for that contribution year exceeds $50,000”.


Schedule 3—Technical correction

 

Medical Indemnity Act 2002

1  Paragraph 58(c)

Omit “contribution”, substitute “payment”.

Note: This amendment fixes an incorrect term.

 

 

 

[Minister’s second reading speech made in—

House of Representatives on 16 June 2005

Senate on 10 August 2005]

(89/05)

 

Overview

The Medical Indemnity Legislation Amendment (Competitive Neutrality) Act 2005 was enacted by the Parliament of Australia to address the issue of competitive advantage within the medical indemnity sector. The Act amends the Medical Indemnity Act 2002 and the Medical Indemnity (UMP Support Payment) Act 2002, primarily to introduce competitive advantage payments by medical indemnity insurers, ensuring that any assistance provided to certain organisations does not confer an unfair competitive benefit. This amendment aims to maintain a level playing field in the medical indemnity market by requiring specific payments that reflect the competitive advantage enjoyed by participating medical indemnity organisations and their associated insurers. The Act came into force on various dates, with sections 1 to 3 and unspecified provisions commencing on the day of Royal Assent, 19 October 2005. Schedules 1 and 2 took effect from 1 July 2005, while Schedule 3 applied immediately after the commencement of Schedule 2 to the Medical Indemnity Legislation Amendment (Run-off Cover Indemnity and Other Measures) Act 2004 on 1 July 2004. The overarching policy objective of this legislation is to ensure competitive neutrality within the medical indemnity sector by mandating specific payments from medical indemnity insurers.

Scope and Application

The Medical Indemnity Legislation Amendment (Competitive Neutrality) Act 2005 amends the Medical Indemnity Act 2002 and the Medical Indemnity (UMP Support Payment) Act 2002 to introduce and regulate competitive advantage payments for medical indemnity insurers. This Act applies to medical indemnity insurers, which are entities providing insurance or indemnity arrangements for medical practitioners against claims for professional negligence. The Act's jurisdictional reach is federal, impacting the operation of these insurers across Australia. Certain provisions of the Act commenced on the date of Royal Assent, 19 October 2005, while other sections commenced on 1 July 2005. The Act extends its application through subordinate instruments that may specify exemptions or other details concerning the competitive advantage payments. The Act includes detailed provisions for determining the amount and timing of competitive advantage payments, exemptions from these payments, and the process for assessing and reporting on the net IBNR (Incurred But Not Reported) exposure of medical indemnity organisations. The Act also incorporates technical corrections to ensure consistency and accuracy within the legislative framework.

Key Provisions

The Medical Indemnity Legislation Amendment (Competitive Neutrality) Act 2005 primarily amends the Medical Indemnity Act 2002 and the Medical Indemnity (UMP Support Payment) Act 2002, with additional amendments to the Health Insurance Act 1973, the Health Insurance Commission Act 1973, and the National Health Act 1953. The Act introduces a new concept of a competitive advantage payment to ensure that assistance provided to certain medical indemnity organisations does not unfairly advantage those organisations. It also adjusts the criteria and amounts for UMP support payments and makes a technical correction to the Medical Indemnity Act 2002. The Act imposes specific obligations on medical indemnity insurers and other relevant parties. Firstly, it requires medical indemnity insurers to make competitive advantage payments based on the net IBNR (Incurred But Not Reported) exposure of the medical defence organisations they participate with. This payment is intended to neutralise any competitive edge that the assistance provided to these organisations might otherwise give them. Secondly, the Act mandates the Actuary to annually reassess and report on the net IBNR exposure of participating medical defence organisations. This reassessment ensures that the competitive advantage payments are reflective of the actual competitive advantage enjoyed by the organisations. Thirdly, the Health Insurance Commission is authorised to request specific information from participating medical defence organisations to assist the Actuary in making these assessments. Failure to comply with the requirements of the Act can result in civil consequences. For instance, if a participating medical defence organisation fails to comply with a request for information from the Health Insurance Commission, it can be considered an offence. Additionally, the Act outlines procedures for the recovery of overpaid competitive advantage payments and late payment penalties. It also specifies the method and timing for making these payments, with late payment incurring additional penalties. In summary, the Medical Indemnity Legislation Amendment (Competitive Neutrality) Act 2005 introduces new payment requirements for medical indemnity insurers, mandates annual reassessments of medical defence organisations' net IBNR exposure, and provides mechanisms for information gathering and enforcement. These provisions are designed to maintain competitive neutrality in the medical indemnity sector.

Legal classification tags

Area of Law
Medical Law
Instrument
Act
Concepts
Commencement Provisions
Regulatory Standards
Reporting & Disclosure Obligations

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.